Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation.
about
The aetiology and impact of malnutrition in paediatric inflammatory bowel diseaseIron deficiency anemia in inflammatory bowel diseaseAnemia in inflammatory bowel disease: an under-estimated problem?Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitisPreventive health measures in inflammatory bowel diseaseIron regulation by hepcidinIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNutritional approaches for managing obesity-associated metabolic diseases.A novel immunological assay for hepcidin quantification in human serumTargeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemiasPrevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.Transport proteins promoting Escherichia coli pathogenesis.Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota.Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study.Hepcidin in beta-thalassemia.Diagnosis and management of iron deficiency anemia in patients with IBD.The role of iron in the immune response to bacterial infectionNutritional status and growth in Korean children with Crohn's disease: a single-center studyIron and inflammation - the gut reaction.Cross-talk between iron homeostasis and intestinal inflammation.Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.Pro- and anti-inflammatory cytokines during immune stimulation: modulation of iron status and red blood cell profileAn Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease.The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel diseaseIron and immunity: immunological consequences of iron deficiency and overload.Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemiaRed cell distribution width: a novel marker of activity in inflammatory bowel diseaseManagement of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic ReviewIron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel diseasePathophysiology of Iron Homeostasis during Inflammatory States.Divalent metal-ion transporter 1 is decreased in intestinal epithelial cells and contributes to the anemia in inflammatory bowel disease.Role of hepcidin in the pathophysiology and diagnosis of anemia.Intestinal ferroportin expression in pediatric Crohn's disease.Iron and intestinal immunity.Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease.Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.Characterization and pathogenesis of anemia in glycogen storage disease type Ia and IbAnemia and inflammatory bowel diseasesAnti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion
P2860
Q22242626-4958E962-C4D8-4FD6-A484-336CD5E03E07Q26795390-3C0E2D21-373E-4A87-B2D0-0DBF25370533Q26860882-96358BAA-F1FE-4529-8843-607C46FE2365Q27301826-6132BA63-CC32-4FB4-A9D8-F3FDAFBA531BQ28078112-73AF27AB-BDED-4A60-9BC5-11CFBF427643Q28291718-2B8F5EFC-3CCC-4026-8F00-F62FA80F20E1Q28388335-4A18D07E-7944-4E86-B82A-A287EABA7782Q30234850-8B1EBF1C-7F7B-4E80-813F-A97E022F84FAQ33411750-6B000133-439E-4B1F-A509-643E01CBE0C2Q33559201-4E676AC2-7D2C-45B5-8DA5-640CE93EE7E9Q33632204-342D908A-9339-4C2A-A84F-07A08CCD254BQ33931575-D92B0A20-F16C-4921-90DA-6992984B9A90Q33940769-74DB527B-6146-4D42-95B2-4480871FE065Q34035106-E2F8BC99-9015-4C0A-A82B-C41C7409B769Q34076870-5B45D3CB-31C4-4952-99EA-B08E261DED08Q34141999-3E8D949D-C4BD-4E38-9146-C3C56BC86480Q34155194-92D40F18-93EB-41EB-98E4-FD1713101F4CQ34182085-470AED27-8AD9-4962-8F84-496960D69F72Q34548797-4CD02D50-D2E8-42FA-916C-9B69F47940C8Q34558183-3C6FD874-363E-4818-A18D-DDC2C68B6155Q34710712-8BAFFD7C-C14F-45AB-B278-F71A9A208532Q34909510-B299FF44-D68C-455D-88D4-BEFD085ECAF6Q34985859-34790FC9-3D0B-44BB-A944-1F1517A01448Q35116191-B03938E0-FC86-4B4C-9F82-034570639B7FQ35214752-644957FF-0E04-4286-A93F-6BDDCD7D480EQ35594086-B96E573E-BF48-4CB5-9435-54B96CB25D13Q35619156-D6A942F8-9EE5-41E7-86F8-B33B0E9C0A89Q35659768-4E547CCA-9AF2-400D-8E65-36AC5B20FD12Q36043365-091E15CC-9107-4700-9646-917D3EA6FA20Q36056154-86D3F3E2-2D9D-4551-B1D6-12D5311EFB9EQ36287635-37E800F6-CE34-456C-AF1A-063E7C7CCEBBQ36761787-6C1F02ED-BEEB-4C30-8AF8-6E1F2BE0424EQ37069008-4EA2AAF6-E8A8-4FAA-BF64-63094FE72CDBQ37072752-468864C0-3FBC-4026-907E-970AC38E4AE0Q37118393-26DA6807-FC45-47FA-9C7B-D14CFB56AC1DQ37162713-AF621097-C353-46DE-B697-86A37BD5A9E6Q37204047-B0B37CCF-ABC9-4753-A063-D7D79ECFDEF7Q37256762-081F2255-8CDA-42F5-A0C1-2136311D886CQ37605066-A670A379-101C-4100-8FE5-AE42899A0E8FQ37612050-56C8EAC2-A5CF-4BE3-9C46-A5A3295A9A49
P2860
Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impaired intestinal iron absor ...... y and markers of inflammation.
@en
Impaired intestinal iron absor ...... y and markers of inflammation.
@nl
type
label
Impaired intestinal iron absor ...... y and markers of inflammation.
@en
Impaired intestinal iron absor ...... y and markers of inflammation.
@nl
prefLabel
Impaired intestinal iron absor ...... y and markers of inflammation.
@en
Impaired intestinal iron absor ...... y and markers of inflammation.
@nl
P2093
P2860
P1476
Impaired intestinal iron absor ...... y and markers of inflammation.
@en
P2093
Andrew C Saunders
Anna Zholudev
Athos Bousvaros
Catherine E Correia
David A Weinstein
Douglas S Fishman
Elizabeta Nemeth
Gaith Semrin
Richard J Grand
P2860
P304
P356
10.1097/01.MIB.0000235097.86360.04
P577
2006-12-01T00:00:00Z